Japan Today reports with the rapid growth in cancer worldwide a considerable shortage of oncologists will create the need for innovative solutions.
The World Health Organization (WHO) projects great increases in the demand for therapy such as chemotherapy reported recently in The Lancet Oncology.
The demand for chemotherapy will rise from 9.8 million to 15 million by 2040 according to Australian researchers. They note nearly 70% of these cases will be from low and middle-income countries. The research team used a computer simulation to project the demand for chemotherapy would rise from 65,000 in 2018 to 100,000 in 2040.
Brooke Wilson, a researcher with the University of New South Wales and the Collaboration for Cancer Outcomes, Research and Evaluation at the Ingham Institute for Applied Medical Research is quoted- “The rising global cancer burden is undoubtedly one of the major health crisis of today.” He continues “Strategies are urgently needed to equip the global health workforce to enable safe treatment of current and future patients. Counties and institutions should use our data to estimate their future cancer physician workforce requirements and chemotherapy needs and plan national, regional and global strategies to ensure all those who need it will have access to chemotherapy treatment.”
Follow the link for more on this research report. It should become apparent global shortages in oncology specialists, including chemotherapy specialists is both a crisis and an opportunity for innovative solutions that heretofore haven’t been considered.
Dr. Brooke Wilson, researcher with the University of New South Wales, the Collaboration for Cancer Outcomes, Research and Evaluation at the Ingham Institute for Applied Medical ResearchSource: Japan today